Clinical trial · Observational
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma. (Retrospective-cohort Study)
NCT03109457CI-TRIAL-00043172completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Compare Hepatiis C Virus (HCV) detection between oral squamous cell carcinoma (OSCC) and normal tissues, to determine the possible relationship between HCV and OSCC.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatitis C | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| oral squamous cell carcinoma | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Oral squamous cell carcinoma
- description
- Sections (4-5 microns thick) will be cut for the immunohistochemical procedure, from each paraffin block and placed on positively charged (Opti-plus) slides by the technicians in the Oral and Maxillofacial laboratory setting. Hep C cAg : sc-58144, santa cruz biotechnology, USA) a mouse monoclonal antibody raised against Hepatitis C virus will be purchased and used for immunohistochemical staining.
- interventionNames
- Other: oral squamous cell carcinoma
- label
- Control
- description
- Sections (4-5 microns thick) will be cut for the immunohistochemical procedure, from each paraffin block and placed on positively charged (Opti-plus) slides by the technicians in the Oral and Maxillofacial laboratory setting. Hep C cAg : sc-58144, santa cruz biotechnology, USA) a mouse monoclonal antibody raised against Hepatitis C virus will be purchased and used for immunohistochemical staining.
- interventionNames
- Other: oral squamous cell carcinoma
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. Presence of sufficient paraffin-embedded tumor material; 2. Presence of oral cavity cancer (including oral tongue, floor of mouth, gingiva, lips, buccal mucosa) 3. Absence of recurrent head and neck cancer 4. Absence of previous oncologic therapy; 5. Histological-proven squamous cell carcinoma. \- Exclusion Criteria: subjects with missing information on age or sex will be excluded. \-
References
Publications (0)
Data not yet available
No reference posted for this study.